Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Cash flows from operating activities:
Net income	$ 615,572	$ 445,556
Non-cash and other reconciling items:
Depreciation	59,870	65,719
Amortization	5,169	12,034
Amortization of Operating Lease Assets	39,962	40,298
Deferred income taxes	(11,053)	1,423
Stock-based compensation	30,057	28,638
Other, net	7,986	47,667
Changes in (net of effects from businesses acquired and divested):
Receivables	(320,097)	(880,957)
Inventories	(1,033,381)	(549,999)
Accounts payable	(331,352)	628,822
Accrued expenses and other, net	(10,974)	141,381
Net cash flows used for operating activities	(948,241)	(19,418)
Cash flows from financing activities:
Issuance of notes, net of discounts	498,615
Borrowings under accounts receivable securitization, net	261,000	57,400
Borrowings under senior unsecured credit facility, net	763,991
Borrowings (repayments) under bank credit facilities and other debt, net	(90,256)	117,982
Repurchases of common stock	(221,282)	(88,952)
Dividends paid on common stock	(79,807)	(73,253)
Other, net	(9,814)	(16,853)
Net cash flows provided by (used for) financing activities	1,122,447	(3,676)
Cash flows from investing activities:
Purchases of property, plant and equipment	(137,804)	(33,679)
Proceeds from liquidation of Company Owned Life Insurance Policies		84,343
Other, net	(16,326)	724
Net cash flows (used) provided by investing activities	(154,130)	51,388
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	12,168	(28,528)
Cash and cash equivalents:
increase (decrease)	32,244	(234)
Cash and cash equivalents at beginning of year	153,693	199,691
Cash and cash equivalents at end of year	$ 185,937	$ 199,457